Wuxi Pharmaceutical Ming Kand New Drug Development Co., Ltd. conducted multiple share repurchases of A shares from March 8 to April 11, 2024. Under the Listing Rules of the Hong Kong Stock Exchange Limited, companies are required to disclose changes in shares. During this period, the company has repurchased millions of shares, with a detailed record of the number of shares repurchased and the date of the change. The repurchase price is sometimes a discount compared to the market price, and sometimes it is a premium. The Company repurchased 452,158 shares of A-shares for a total amount of approximately RMB 2004 million during the repurchase event on April 11, 2024. The repurchase took place on the Shanghai Stock Exchange and confirmed compliance with the relevant rules of the local exchange.

Wuxi Pharmaceutical Ming Kand New Drug Development Co., Ltd. conducted multiple share repurchases of A shares from March 8 to April 11, 2024. Under the Listing Rules of the Hong Kong Stock Exchange Limited, companies are required to disclose changes in shares. During this period, the company has repurchased millions of shares, with a detailed record of the number of shares repurchased and the date of the change. The repurchase price is sometimes a discount compared to the market price, and sometimes it is a premium. The Company repurchased 452,158 shares of A-shares for a total amount of approximately RMB 2004 million during the repurchase event on April 11, 2024. The repurchase took place on the Shanghai Stock Exchange and confirmed compliance with the relevant rules of the local exchange.